Strep A: challenges, opportunities, vaccine-based solutions, and economics

David E. Bloom; Jonathan Carapetis

doi:10.1038/s41541-024-00863-7

npj Vaccines (Apr 2024)

Strep A: challenges, opportunities, vaccine-based solutions, and economics

David E. Bloom,
Jonathan Carapetis

Affiliations

David E. Bloom: Harvard T.H. Chan School of Public Health
Jonathan Carapetis: Wesfarmers Centre for Vaccines and Infectious Diseases, Telethon Kids Institute, University of Western Australia

DOI: https://doi.org/10.1038/s41541-024-00863-7
Journal volume & issue: Vol. 9, no. 1
pp. 1 – 7

Abstract

Read online

Abstract This collection of articles focuses on Streptococcus pyogenes (Strep A) vaccine research and innovation, with a focus on emerging efforts to understand and estimate the full societal value of Strep A vaccination.

Published in npj Vaccines

ISSN: 2059-0105 (Online)
Publisher: Nature Portfolio
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Specialties of internal medicine: Immunologic diseases. Allergy; Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Website: https://www.nature.com/npjvaccines/

About the journal